This Week s Most Popular Stories About ADHD Medication Pregnancy ADHD Medication Pregnancy
ADHD Medication During Pregnancy and Breastfeeding
Women with ADHD must make a difficult decision on whether to keep or stop taking ADHD medication during pregnancy and breastfeeding. There isn't much information on how long-term exposure to these medications could affect the fetus.
A study recently published in Molecular Psychiatry shows that children exposed to ADHD medication during the uterus don't develop neurological developmental disorders such as hearing loss or impaired vision seizures, febrile seizures, or IQ impairment. The authors acknowledge that further high-quality studies are needed.
Risk/Benefit Analysis
Pregnant women who take ADHD medications need to balance the advantages of taking them against potential risks to the foetus. The doctors don't have the information to give clear advice but they can provide information about risks and benefits to help pregnant women make informed decisions.
A study published in Molecular Psychiatry found that women who were taking ADHD medications during their early pregnancy did not have an higher risk of fetal cardiac malformations or major structural birth defects. Researchers conducted a large population-based case control study to assess the frequency of major structural defects in infants who were born to mothers who took stimulants during pregnancy. Pediatric cardiologists and clinical geneticists examined the cases to ensure correct case classification and to limit the possibility of bias.
However, the researchers' study was not without its flaws. Most important, they were unable to separate the effects of the medication from the effects of the disorder that is underlying. That limitation makes it difficult to know whether the small associations observed in the exposed groups are due to the use of medication or the confounding effect of comorbidities. The researchers also did not look at long-term outcomes for the offspring.
The study showed that infants whose mothers took ADHD medication during pregnancy were at a slightly higher risk of admission to the neonatal care unit (NICU) in comparison to those whose mothers did not use any medication during pregnancy or stopped taking their medication before or during pregnancy. The reason for this was central nervous system-related disorders and the increased risk for admission was not found to be affected by the type of stimulant medication was used during pregnancy.
Women who took stimulant ADHD medications during pregnancy also had a higher likelihood of having an emergency caesarean section or having the baby was not scoring well on the Apgar scale (less than 7). These increases appeared to be unrelated to the type of medication used during pregnancy.
Researchers suggest that the small risks posed by the use of ADHD medication during pregnancies in the early stages may be offset by the more beneficial outcomes for both baby and mother of continued treatment for the woman's condition. Physicians should discuss the issue with their patients and, if possible, assist them in developing strategies for improving their coping skills that can lessen the impact of her disorder on her daily life and relationships.
Interactions with Medication
As more women than ever before are being diagnosed with ADHD and being treated with medication, the issue of whether to keep or end treatment during pregnancy is one that doctors are having to face. Often, these decisions are taken in the absence of any evidence that is clear and definitive in either case, which means that doctors have to weigh their experience from their own experiences, those of other doctors, and what research says on the topic as well as their best judgment for each individual patient.
Particularly, the subject of possible risks to the baby can be tricky. The research on this issue is based on observations instead of controlled studies and the results are conflicting. The majority of studies limit their analysis to live-births, which could underestimate the severity of teratogenic effects which can cause abortions or terminations of pregnancy. The study discussed in the journal club addresses these issues by analyzing information on deceased and live births.
Conclusion A few studies have shown an association between ADHD medications and certain birth defects However, other studies haven't found a correlation. The majority of studies show that there is a neutral, or slight negative impact. In each case an in-depth study of the risks and benefits is required.
It can be difficult, if not impossible for women suffering from ADHD to stop taking their medication. In an article recently published in the Archives of Women's Mental Health psychologist Jennifer Russell notes that stopping ADHD medication during pregnancy can increase depression, feelings of isolation and family conflict for these patients. The loss of medication can also impact the ability to safely drive and perform work-related tasks, which are essential aspects of everyday life for those suffering from ADHD.
She suggests that women who aren't sure whether to continue taking the medication or stop it due to their pregnancy, educate their family members, coworkers and acquaintances about the condition, its effects on daily functioning, and the benefits of continuing the current treatment regimen. It can also help a woman feel more confident in her decision. Certain medications can be passed through the placenta. If the patient decides not to take her ADHD medication while breastfeeding, it is crucial to be aware that the medication could be transferred to the baby.
Birth Defects and Risk of
As the use of ADHD drugs to treat symptoms of attention deficit hyperactivity disorder (ADHD) increases there are concerns about the effects that the drugs might have on foetuses. A recent study published in the journal Molecular Psychiatry adds to the existing knowledge about this subject. Researchers used two massive data sets to study over 4.3 million pregnancies and determine if stimulant medication use caused birth defects. While the overall risk remains low, the researchers discovered that the first-trimester exposure to ADHD medicines was associated with an increase in the risk of certain heart defects such as ventriculoseptal defect (VSD).
The authors of the study didn't find any association between early medication usage and other congenital anomalies, such as facial deformities or club feet. The results are in agreement with previous studies which showed the existence of a slight, but significant increase in cardiac malformations for women who began taking ADHD medication prior to the time of the time of pregnancy. This risk increased during the latter part of pregnancy, when many women decide to stop taking their ADHD medications.
Women who took ADHD medication in the first trimester of pregnancy were also more likely to have caesarean section, low Apgar score after delivery and a baby that required help breathing at birth. However the researchers of the study were not able to eliminate bias due to selection by restricting the study to women who did not have other medical issues that could be a contributing factor to these findings.
Researchers hope that their research will inform physicians when they see pregnant women. They recommend that, while discussing risks and benefits is important, the decision to stop or keep treatment should be based on the woman's requirements and the severity of her ADHD symptoms.
The authors also caution that even though stopping adhd medication Adults (bastombuva.uz) the medication is an alternative, it is not an option to consider due to the high prevalence of depression and other mental health issues in women who are pregnant or who are recently post-partum. Further, the research suggests that women who decide to stop their medications are more likely to experience a difficult time adjusting to life without them after the baby's arrival.
Nursing
The responsibilities of a new mother can be overwhelming. Women with ADHD who must work through their symptoms while attending doctor appointments, getting ready for the arrival of a baby and adapting to new routines in the home may face a lot of challenges. This is why many women decide to continue taking their ADHD medications throughout pregnancy.
The majority of stimulant drugs pass through breast milk in low amounts, so the risk to the infant who is breastfeeding is low. The rate of exposure to medication will differ based on dosage, frequency of administration and the time of day. In addition, individual medications enter the infant's system differently through the gastrointestinal tract and breast milk and the impact of this on a newborn infant is not well known.
Due to the absence of research, some doctors may be inclined to discontinue stimulant drugs during the course of pregnancy. It's a difficult choice for the mother, who must weigh the advantages of her medication against the risks to the fetus. As long as there is no more information, doctors should ask all pregnant patients about their history of ADHD and whether they plan or are taking to take medication during the perinatal time.
A increasing number of studies have proven that most women can safely continue taking their adhd medication guide medication during pregnancy and while breastfeeding. This has led to an increasing number of patients choose to do so, and in consultation with their doctor they have discovered that the benefits of maintaining their current medication far exceed any risk.
It's important for women with ADHD who are thinking of breastfeeding to seek a specialist psychiatrist's advice prior to becoming pregnant. They should discuss their medication with their prescriber and discuss the advantages and disadvantages of continuing treatment, including non-pharmacological management strategies. Psychoeducation should also be offered to help pregnant women suffering from ADHD recognize their symptoms and underlying disorder and learn about treatment options and reinforce existing strategies for coping. This should include a multidisciplinary approach with the GP doctors, obstetricians and psychiatrists. Pregnancy counselling should include discussion of a management plan for both the mother and child, as well as monitoring for signs of deterioration, and the need for adjustments to the medication regimen.